Melanoma Bridge 2023
R

Targeted Therapy in BRAF-Mutated Metastatic Melanoma

By Melanoma Bridge 2023 FEATURING Reinhard Dummer
By Melanoma Bridge 2023 FEATURING Reinhard Dummer
0 views
January 9, 2024
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
10:01
AAD 2024 Insights

AAD 2024 Insights: The Latest Advances in the Treatment of Melanoma

Feat. V. Sondak
11:05
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, …

Feat. D. Johnson
35:23
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

Feat. S. Patel
25:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Insights in Melanoma"

Feat. O. Hamid
18:28
Vanderbilt University Medical Center (VUMC)

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Feat. D. Johnson
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
03:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib …

Feat. A. Hauschild
25:44
Scripps Health

Melanoma in the Molecular Age - Part 1: New Tools for Diagnosis, Pro…

Feat. G. Hosler
24:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and A…

Feat. Z. Eroglu
17:07
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

Melanoma Brain Metastases: Successes, Failures, and Future Opportuni…

Feat. M. Postow
11:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We B…

Feat. P. Corrie
20:16
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Immunotherapy & Beyond - Advances in S…

Feat. H. Tawbi
05:37
Melanoma Bridge 2023

COLUMBUS 7-Year Update: Encorafenib + Binimetinib vs. Vemurafenib or…

Feat. R. Dummer
21:29
14th Annual LA Melanoma Symposium

Clinical Trial Options for Melanoma: New Data and Future Therapies

Feat. R. Sullivan
22:58
Tarek Haykal

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

15:18
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Adopting Cutting-Edge Cell Therapies in Me…

Feat. A. Betof Warner
14:42
Jeff Yorio

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

14:23
Alexander Van Akkooi

Advantages & Disadvantages of Adjuvant IO vs. Targeted Treatment…